ALBANY, New York, April 4, 2017 – MarketResearchReports.biz announces the availability of a new report to its repository, titled “Global Cancer Diagnostics Industry 2017, Trends and Forecast Report.” The report overviews the latest technological advancements in the diagnostic methods pertaining to long-standing chronic disease such as cancer, and aims to serve as a credible business document for the audiences such as pharmaceutical companies, diagnostic equipment vendors, research institutes, and traders, suppliers, and distributors of cancer diagnostic tools. The report studies the trends of the market for cancer diagnostics across the world and forecasts the scenario until 2021.
According to the American Cancer Society, 14.1 million new cancer cases were detected across the globe, out of which 8.2 million patients succumbed to the disease. The American Cancer Society report estimates the number of patients to multiply to 21.7 million by 2030. This escalating number of patients is the primary factor driving the demand in the global cancer diagnostics market. In addition to that, early detection of cancer is of optimum valuation as far as therapy and recovery is concerned. With rising disposable income across the urban population, consumers are now investing for early detection of cancer cases with latest diagnostic equipment, and thereby incrementing the demand for the same. Improving healthcare infrastructure across several emerging economies, favorable government policies and funding, and rising awareness about the prevalence of cancer among the end users are some of the other favorable factors for this market.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/938127
Moreover, the advent of new cancer detection techniques such as genomics, metabolomics, proteomics, and transcriptomics are expected to have huge positive influence over the market until 2021. With growing awareness about the availability of these detection techniques, consumers are willing to go through diagnostics without glaringly apparent symptoms. However, there are still no absolute therapeutics to completely eliminate cancer, which is installing lack of faith among the consumers and thereby hindering the growth rate of the global cancer diagnostics industry.
The report picks out all the three important regions in the global cancer diagnostics industry: Asia Pacific, Europe, and North America, and provides capacity production overview, production market share, demand overview, import and export consumption, supply demand and shortage, and cost production value gross margin of each of the regions. This report also contains product development history, market development trend, and the nature of competitive landscape in all the three important regions of the players in the global cancer diagnostics industry. The report also provides some of the key manufacturers in the market, giving an overview of their products and specification, applications, geographical presence, production capacity, pricing, and margin.
Some of the key countries identified by the report for the players to focus on are the U.S., the U.K., Japan, Germany, China, and South Korea. A few other featured chapters in this 156-page include cancer diagnostics marketing channels development proposals, development environmental analysis, and new project investment feasibility.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org